Laboratory identity number | TOSV (positive n=2) | TOSV (Lineage A and B), Ct | %b | Negative (n=6) | Pan-SFSV (positive n=1) | SFSV Cta | %b | Negative (n=7) | Pan-Phlebovirus (positive n=6) | Detected phlebovirusesc | %b | Negative (n=2) | Totalb |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reference Laboratory | 2 | TOSV A 26.2 TOSV B 26.4 | 100 | 6 | 1 | 26.0 | 100 | 7 | 6 | PUNV,ARBV, MASV, SFSV, TOSV A and B | 100 | 2 | 100% |
1 | 2 | TOSV A 26.6 TOSV B 27.1 | 100 | 6 | 1 | 26.0 | 100 | 7 | 6 | PUNV,ARBV, MASV, SFSV, TOSV A and B | 100.0 | 2 | 100.0% |
2 | 2 | TOSV A 28.9 TOSV B 28.1 | 100 | 6 | 1 | 28.6 | 100 | 7 | 5 | PUNV,ARBV, MASV, SFSV, TOSV A | 83.3 | 3 | 83.3% |
3 | 2 | TOSV A 32.8 TOSV B 32.1 | 100 | 6 | 1 | 29.2 | 100 | 7 | 2 | PUNV,ARBV, | 33.3 | 6 | 77.7% |
4 | 2 | TOSV A 25.9 TOSV B 26.1 | 100 | 6 | 1 | 23.3 | 100 | 7 | 3 | PUNV,ARBV, MASV | 50.0 | 5 | 83.3% |
5 | 2 | TOSV A 30.0 TOSV B 30.0 | 100 | 6 | 1 | 31.0 | 100 | 7 | 5 | PUNV,ARBV, MASV, SFSV, TOSV A | 83.3 | 3 | 94.4% |
6 | 2 | TOSV A 31.8 TOSV B 33.4 | 100 | 6 | 1 | 28.8 | 100 | 7 | 5 | PUNV,ARBV, MASV, SFSV, TOSV A | 83.3 | 3 | 94.4% |
7 | 2 | TOSV A 31.2 TOSV B 33.5 | 100 | 6 | 1 | 29.7 | 100 | 7 | 3 | PUNV,ARBV, MASV | 50.0 | 5 | 83.3% |
8 | 2 | TOSV A 28.9 TOSV B 29.5 | 100 | 6 | 1 | 27.1 | 100 | 7 | 5 | PUNV,ARBV, MASV, SFSV, TOSV A | 83.3 | 3 | 94.4% |
9 | 2 | TOSV A 31.0 TOSV B 32.0 | 100 | 6 | 1 | 30.0 | 100 | 7 | 3 | PUNV,ARBV, MASV | 50.0 | 5 | 83.3% |